1
|
Melcarne R, Docimo G, Aiello PSL, Andreani S, Avenia N, Basili G, Bellotti C, Bettini D, Biffoni M, Bononi M, Bove A, Calò PG, Casaril A, Cavallaro G, Chiofalo MG, Consorti F, De Crea C, De Pasquale L, Del Rio P, Dobrinja C, Giacomelli L, Graceffa G, Gurrado A, Iacobone M, Innaro N, Leopaldi E, Lupone G, Materazzi G, Minuto M, Mullineris B, Palestini N, Panconesi R, Pauna I, Pezzolla A, Pisano IP, Princi P, Quaglino F, Raffaelli M, Rosato L, Sartori PV, Scerrino G, Scolari F, Testini M, Traini E, Boniardi M. Intraoperative nerve monitoring in thyroid and parathyroid surgery: a decade of Italian practice. Updates Surg 2025:10.1007/s13304-025-02157-6. [PMID: 40169508 DOI: 10.1007/s13304-025-02157-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2024] [Accepted: 02/26/2025] [Indexed: 04/03/2025]
Abstract
Intraoperative nerve monitoring (IONM) has been recognized as a useful adjunct into the field of thyroid and parathyroid surgery, aiding in the accurate identification and preservation of the recurrent laryngeal nerve (RLN), consequently reducing the probability of nerve injury and promoting surgical safety. This investigation seeks to amplify the findings of a similar nationwide survey performed in 2014 by offering an updated assessment of IONM practices among Italian surgical institutions, reflecting a decade of advancements and transformations in clinical approaches. A comprehensive nationwide survey was implemented targeting Italian endocrine surgeons to assess the prevalence, utilization patterns, attitudes and perceptions surrounding IONM in the context of thyroid and parathyroid surgical procedures. Structured questionnaires were administered to seventy endocrine surgery centers, and the resulting data were evaluated employing both quantitative and qualitative analysis methods. The survey disclosed that 67.14% of the participants confirmed the routine deployment of IONM across all cervical surgical procedures, particularly in high-risk contexts. Relative to the findings from 2014, a marked rise in the implementation of IONM has been recorded; however, variability persists, especially between continuous and intermittent monitoring strategies. Surgeons recognized improved surgical safety, decreased complication frequencies, and educational advantages as significant key drivers for the incorporation of IONM. Nonetheless, issues, such as false-positive and false-negative results, along with the lack of standardized protocols, remain barriers to its uniform application. During the past ten years, IONM has been thoroughly adopted by Italian endocrine surgeons as a result of its critical contribution to the improvement of surgical outcomes and the provision of educational resources. However, the results highlight the imperative for further standardization of protocols, the advancement of training programs, and the resolution of reimbursement obstacles to ensure equitable and consistent application of IONM across Italian centers, ultimately optimizing patient care.
Collapse
Affiliation(s)
- R Melcarne
- Department of Translational and Precision Medicine, Sapienza University of Rome, Viale del Policlinico, 155, 00161, Rome, Italy.
| | - G Docimo
- Division of Thyroid Surgery, University of Campania "L. Vanvitelli", Naples, Italy
| | - P S L Aiello
- Endocrine Surgery Unit, Department of General Oncology and Mini-Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, 20162, Milan, Italy
| | - S Andreani
- Endocrine Surgery Unit, Department of General Oncology and Mini-Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, 20162, Milan, Italy
| | - N Avenia
- General and Endocrine Surgery Unit, S. Maria University Hospital, University of Perugia, 05100, Terni, Italy
| | - G Basili
- General Surgery Department, Endocrine Surgery Unit, Azienda USL Toscana Nord-Ovest, Pontedera, Italy
| | - C Bellotti
- Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale, Università Sapienza di Roma, Rome, Italy
| | - D Bettini
- Endocrine Surgery Unit, "Morgagni-Pierantoni" Hospital, Forli, Italy
| | - M Biffoni
- UOSD Endocrine Surgery - Department of General and Speciality Surgery, Sapienza University, 00185, Rome, Italy
| | - M Bononi
- Department of Surgery, Sapienza University, Rome, Italy
| | - A Bove
- Department of Medicine, Dentistry and Biotechnology, University "G. D'Annunzio", Chieti, Italy
| | - P G Calò
- Department of Surgical Sciences, University of Cagliari, Cagliari, Italy
| | - A Casaril
- Endocrine Surgery Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy
| | - G Cavallaro
- Department of Surgery, Sapienza University, Rome, Italy
| | - M G Chiofalo
- Pathology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy
| | - F Consorti
- Department of Surgery, Sapienza University, Rome, Italy
| | - C De Crea
- UOC Chirurgia Endocrina, Ospedale Isola Tiberina, Gemelli Isola, Rome, Italy
- Centro di Ricerca in Chirurgia delle Ghiandole Endocrine e dell'Obesità, Università Cattolica del Sacro Cuore, Rome, Italy
| | - L De Pasquale
- Thyroid Unit, Department of Health Sciences, Santi Paolo e Carlo Hospital, Università degli Studi di Milano, Milan, Italy
| | - P Del Rio
- Unit of General Surgery, Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - C Dobrinja
- General Surgery Unit, Department of Medicine, Surgery and Health Sciences, University of Trieste, Cattinara University Hospital, Strada di Fiume 447, 34149, Trieste, Italy
| | - L Giacomelli
- UOSD Endocrine Surgery - Department of General and Speciality Surgery, Sapienza University, 00185, Rome, Italy
| | - G Graceffa
- Department of Surgical Oncological and Oral Sciences, University of Palermo, 90127, Palermo, Italy
| | - A Gurrado
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University Medical School of Bari, 70124, Bari, Italy
| | - M Iacobone
- Endocrine Surgery Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padua, Italy
| | - N Innaro
- Unit of Endocrine Surgery, AOU "Dulbecco", University "Magna Graecia" of Catanzaro, 88100, Catanzaro, Italy
| | - E Leopaldi
- Surgery Department, IGEA Private Hospital, Milan, Italy
| | - G Lupone
- "A. Cardarelli" Hospital, Naples, Italy
| | - G Materazzi
- Endocrine Surgery Unit, University Hospital of Pisa, Pisa, Italy
| | - M Minuto
- Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - B Mullineris
- Unit of General Surgery, Emergency and New Technologies, Modena Hospital, 41126, Modena, Italy
| | - N Palestini
- Humanitas - Clinica Fornaca di Sessant Private Hospital, Turin, Italy
| | - R Panconesi
- Endocrinology Unit, Careggi Hospital and University of Florence, Florence, Italy
| | - I Pauna
- Endocrine Surgery Unit, Department of General Oncology and Mini-Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, 20162, Milan, Italy
| | - A Pezzolla
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University Medical School of Bari, 70124, Bari, Italy
| | - I P Pisano
- Istituto di Patologia Chirurgica AOU, Sassari, Italy
| | - P Princi
- UOC Centro Multifunzionale di Chirurgia Endocrina, Ospedale Cristo Re, Rome, Italy
| | - F Quaglino
- Department of General Surgery, Maria Vittoria Hospital, ASL City of Turin, Turin, Italy
| | - M Raffaelli
- Centro di Ricerca in Chirurgia delle Ghiandole Endocrine e dell'Obesità, Università Cattolica del Sacro Cuore, Rome, Italy
- UOC Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - L Rosato
- Department of Surgery-ASL TO4, Ivrea Hospital, 10015, Ivrea, Italy
| | - P V Sartori
- General Surgical Department, ASST Brianza-Pio XI Hospital, 20832, Desio, Italy
| | - G Scerrino
- Department of Surgical Oncological and Oral Sciences, University of Palermo, 90127, Palermo, Italy
| | - F Scolari
- Endocrine Surgery Unit, Department of General Oncology and Mini-Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, 20162, Milan, Italy
| | - M Testini
- Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University Medical School of Bari, 70124, Bari, Italy
| | - E Traini
- Endocrine Surgery Unity, Ospedale San Carlo di Nancy GVM, Via Aurelia, 275, 00165, Rome, Italy
| | - M Boniardi
- Endocrine Surgery Unit, Department of General Oncology and Mini-Invasive Surgery, ASST Grande Ospedale Metropolitano Niguarda, 20162, Milan, Italy
| |
Collapse
|
2
|
Durán Poveda M, Martos Martínez JM, Vidal Pérez O, Gluckmann Maldonado E, Quintana De la Basarrate A, Villar Del Moral J, Rodríguez-Caravaca G. Patterns and indications of intraoperative nerve monitoring usage during thyroidectomy and parathyroidectomy in Spain: results of a national survey of endocrine surgeons. Sci Rep 2024; 14:17680. [PMID: 39085408 PMCID: PMC11291499 DOI: 10.1038/s41598-024-68230-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Accepted: 07/22/2024] [Indexed: 08/02/2024] Open
Abstract
We investigated the use patterns and indications of intraoperative neural monitoring (IONM) among endocrine surgeons in Spain. We sent an anonymous web-based survey to endocrine surgeons' members of the Spanish Association of Surgery by email. We analysed 79/ 269 surveys. Respondents had a median age of 52 years and 13 years of surgical experience. Only 32% of respondents performed routinely preoperative laryngoscopy in all thyroidectomies and 19% in all parathyroidectomies. Seventy-five percent of respondents used the intermittent-IONM, and 9.7% used the continuous-IONM. All respondents identified recurrent laryngeal nerve during surgery, and 40% of surgeons routinely identified external branch superior laryngeal nerve (EBSLN) during thyroidectomy. Seventy-eight percent of respondents used IONM always for all thyroidectomies. Only 11% stimulated EBSLN in all cases. Forty-nine percent used IONM always for all parathyroidectomies. The most frequent reasons for not using IONM were the unavailability of IONM, the high cost, and the lack of adding value to their clinical practice. Almost 10% declared not having IONM. The IONM is a reality in Spain, especially the intermittent mode. Its use is superior in thyroid surgery than in parathyroid. Its standardized use is not yet fully established, and routine adherence to standardized guidelines should increase.
Collapse
Affiliation(s)
- Manuel Durán Poveda
- Departamento de Cirugía General y del Aparato Digestivo, Hospital Universitario Rey Juan Carlos, Calle Gladiolo s/n, 28933, Móstoles, Madrid, Spain.
- Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain.
| | - Juan Manuel Martos Martínez
- Departamento de Cirugía General, Hospital Universitario Virgen del Rocío, Sevilla, Spain
- Departamento de Cirugía, Universidad de Sevilla, Sevilla, Spain
| | - Oscar Vidal Pérez
- Departamento de Cirugía General, Hospital Clínic de Barcelona, Barcelona, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Departamento de Cirurgia y Especialidades Medicoquirúrgicas, Universidad de Barcelona, Barcelona, Spain
| | | | - Aitor Quintana De la Basarrate
- Departamento de Cirugía General, Hospital de Cruces, Barakaldo, Bizkaia, Spain
- Departamento Cirugía, Radiología y Medicina Física, Universidad del País Vasco, Leioa, Vizcaya, Spain
| | - Jesús Villar Del Moral
- Departamento de Cirugía General, Hospital Virgen de Las Nieves, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
- Departamento de Cirugía, Universidad de Granada, Granada, Spain
| | - Gil Rodríguez-Caravaca
- Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
- Unidad de Medicina Preventiva, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| |
Collapse
|
3
|
Munk PCB, Merkelbach ME, Lamadé W. The weepy cry - short neural signal bursts in intraoperative neuromonitoring. Langenbecks Arch Surg 2024; 409:102. [PMID: 38514480 PMCID: PMC10957688 DOI: 10.1007/s00423-024-03240-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Accepted: 01/18/2024] [Indexed: 03/23/2024]
Abstract
PURPOSE This study aimed to establish an in-vitro alternative to existing in-vivo systems to analyze nerve dysfunction using continuous neuromonitoring (C-IONM). METHODS Three hundred sixty-three recurrent laryngeal nerves (RLN) (N(pigs) = 304, N(cattle) = 59) from food industry cadavers were exposed by microsurgical dissection following euthanasia. After rinsing with Ringer's lactate, they were tempered at 22 °C. Signal evaluation using C-IONM was performed for 10 min at 2 min intervals, and traction forces of up to 2N were applied for a median time of 60 s. Based on their post-traumatic electrophysiological response, RLNs were classified into four groups: Group A: Amplitude ≥ 100%, Group B: loss of function (LOS) 0-25%, Group C: ≥ 25-50%, and Group D: > 50%. RESULTS A viable in-vitro neuromonitoring system was established. The median post-traumatic amplitudes were 112%, 88%, 59%, and 9% in groups A, B, C, and D, respectively. A time-dependent further dynamic LOS was observed during the 10 min after cessation of strain. Surprisingly, following initial post-traumatic hyperconductivity, complete LOS occurred in up to 20% of the nerves in group A. The critical threshold for triggering LOS was 2N in all four groups, resulting in immediate paralysis of up to 51.4% of the nerves studied. CONCLUSION Consistent with in-vivo studies, RLN exhibit significant intrinsic electrophysiological variability in response to tensile forces. Moreover, nerve damage progresses even after the complete cessation of strain. Up to 20% of nerves with transiently increased post-traumatic amplitudes above 100% developed complete LOS, which we termed the "weepy cry." This time-delayed response must be considered during the interpretation of C-IONM signals.
Collapse
Affiliation(s)
| | - Mick E Merkelbach
- Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- BG Klinikum Murnau, Murnau, Germany
| | - Wolfram Lamadé
- Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- Helios Klinikum Pforzheim, Pforzheim, Germany
| |
Collapse
|